ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Forecast, Price Target & Analyst Ratings
NASDAQ:ANPC • US03635R2067
4.37 USD
-0.25 (-5.41%)
Last: May 19, 2023, 08:11 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANPAC BIO-MEDICAL SCIENC-ADR (ANPC).
Forecast Snapshot
Consensus Price Target
$8.16
+ 86.73% Upside
Next Earnings Forecast
Release DateJun 29, 2023
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.16
Upside
+ 86.73%
From current price of $4.37 to mean target of $8.16, Based on 7 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
ANPC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ANPC.
In the previous month the buy percentage consensus was at a similar level.
ANPC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateJun 29, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 10.85M 5.85% | 20.51M 89.03% | 17.986M -12.31% | |
| EBITDA YoY % growth | -86.42M -113.54% | -90.03M -4.18% | -102.136M -13.45% | |
| EBIT YoY % growth | -89.08M -104.27% | -93.13M -4.55% | -106.046M -13.87% | |
| Operating Margin | -821.01% | -454.07% | -589.60% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ANPAC BIO-MEDICAL SCIENC-ADR / ANPC Forecast FAQ
What is the price target for ANPC stock?
7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37.
When does ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) report earnings?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) will report earnings on 2023-06-29.
How many analysts cover ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) stock?
The number of analysts covering ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) is 7.